BeiGene | Study to Evaluate the Efficacy and Safety of BGB-11417 in Participants With Waldenström's Macroglobulinemia

⟵ Back to Search Results

Study to Evaluate the Efficacy and Safety of Sonrotoclax in Participants With Waldenström’s Macroglobulinemia

Beigene Study ID

BGB-11417-203

ClinicalTrials.gov ID

NCT05952037

EudraCT Number

2023-503235-18

China Drug Trials ID

CTR20232718

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Sex: All

Age: 18 Years / N/A

No Study Documents